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SUMMARY – The aim was to assess glycemia regulation in a blind diabetic patient after getting 
a guide dog. Glycosylated hemoglobin (HbA1c) results of a blind patient before and after getting 
the guide dog were retrospectively collected. The paired t-test results yielded a two-tailed P value 
of 0.0925, a difference considered not statistically significant; the 95% confidence interval of this 
difference varied from -0.2494 to 1.889. An improvement of glycemia regulation was observed with 
the guide dog compared to previous glycemia regulation, however, the difference was not statisti-
cally significant. The moderate improvement could probably be attributed to the mobility of the 
blind person having a guide dog. Standard quality of life tests should be included in the evaluation 
of diabetic blind persons, especially the impact of a guide dog on glycemic control or other chronic 
complications of diabetes. 
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Introduction
Visual impairment is a major cause of morbidity 
in patients with diabetes mellitus. Chronic hypergly-
cemia is thought to be the primary cause of diabetic 
retinopathy, resulting in abnormalities of retinal small 
blood vessels. Diabetic retinopathy is an important 
cause of visual loss and blindness in diabetic pa-
tients1-6. 
According to the World Health Organization 
(WHO) data, in 2002 more than 161 million people 
were visually impaired, of whom 124 million people 
had poor vision and 37 million were blind. The WHO 
has estimated that diabetic retinopathy is responsible 
for 4.8% of the 37 million cases of blindness through-
out the world3-6.
The latest Croatian studies indicate that blind in-
dividuals account for 0.13% of the 4.5 million popu-
lation of Croatia, in total 5800 persons7,8. They are 
registered at the Croatian Association of the Blind. 
The leading causes of blindness in Croatia are myopia, 
diabetic retinopathy and glaucoma. In 212 individu-
als, blindness developed before age 16; in 84 of these, 
retinopathy was due to prematurity7. 
Mobility of a blind person is important from the 
psychological, physical and economic aspects and is 
an important tool of the person’s independence in ev-
eryday life9-13. The blind require mobility training to 
get around safely with a white cane, a guide dog, and/
or electronic mobility aid3-5,9. 
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Guide dogs are assistance dogs trained to lead 
blind or visually impaired people around obstacles. 
Before coupling a blind person and guide dog, evalua-
tion of their matching capabilities should be done. An 
instructor performs training of the dog and the user 
(blind/visually impaired person) during 4-5 weeks, 
and during this period the matching should be com-
pleted. 
Searching through all available databases (Med-
line, PubMed) for data on the impact of a guide dog 
on glycemia regulation in a blind/visually impaired 
person did not yield any associated or similar paper. 
Case Report
We present a 34-year-old male having diabetes 
mellitus type 1 since his age of 3 years and using insu-
lin as therapy for diabetes. During the last ten years, 
the patient presented with progression of diabetic 
retinopathy and maculopathy on both eyes because of 
which he had undergone laser retinal photocoagula-
tion on several occasions. In 1999, pars plana vitrec-
tomy (PPV) and endolaser therapy were consecutively 
done on his both eyes due to vitreous hemorrhage. In 
the next year, blindness of the right eye and severe 
visual impairment on the left eye were established. 
At that time, his blood glucose regulation measured 
by hemoglobin A1c (HbA1c) level was 8.09% (normal 
range, 4.8%-5.7%). Because of blindness, our patient 
requested a guide dog from the Croatian Guide Dog 
and Mobility Association. After checking all medi-
cal records and after psychological evaluation tests, 
matching of the blind person and the guide dog was 
done. The patient took the paired guide dog in Febru-
ary 2004. Insulin therapy included ultra-short acting 
insulin analogue 3 times a day and NPH insulin as 
basal component. Other medications were ramipril 
and furosemide. In that period, laboratory findings 
were as follows: HbA1c 7.63%, creatinine 125 μmol/L, 
creatinine clearance 1.19 mL/s, albumin excretion rate 
in 24-h urine 453 mg/24 h, and protein extraction in 
24-h urine 0.8 mg/24 h.
Eight months after getting the guide dog, the pa-
tient’s HbA1c level was 7.15%. Other laboratory find-
ings were as follows: creatinine 131 μmol/L, creati-
nine clearance 1.24 mL/s, albumin excretion rate in 
24-h urine 393 mg/24 h, and protein extraction in 
24-h urine 0.516 mg/24 h. 
We strongly believe that the glycemia control im-
provement was due to the increased physical activity. 
Using a self-made questionnaire, the patient reported 
an improved quality of life.
Conclusion
Blindness as a disability represents a major socio-
economic issue. Diabetic blind persons usually are 
young or middle aged and become socially incom-
petent for independent living. Decreased or lost in-
dependent physical activity leads to deterioration of 
their quality of life. Insufficient self-monitoring of 
blood glucose because of blindness manifests in wors-
ening of their glycemic control. 
Results of the Diabetes Control and Complica-
tions Trial (DCCT) and the U.K. Prospective Diabe-
tes Study (UKPDS) have demonstrated that improved 
Period mm/YY
Fig. 1. HbA1c values before and 
after guide dog assistance.
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blood glucose control reduces the risk of developing 
retinopathy and slows down the progression of chron-
ic diabetes complications14,15. 
Training for appropriate everyday life activities, 
social integration in the family and occupational en-
vironment, orientation ability and mobility of a blind 
person are very important therapeutic components9-11. 
Guide dogs are already known to be a very effective 
therapeutic tool for blind or hearing impaired persons, 
for mentally ill patients, etc. Their efficiency is due to 
the positive impact on social integration and on per-
sonal positive behavior. 
Physical activity, as well as self-monitoring of 
blood glucose levels, are beneficial in diabetes mel-
litus prevention and management, and represent basic 
nonpharmacological management of diabetes melli-
tus. Vision loss or visual impairment diminishes the 
person’s mobility and independence. Rehabilitation of 
a blind/visually impaired diabetic person is addition-
ally more difficult due to other chronic complications 
(tactile disorders in diabetic patients, constant pains 
due to diabetic neuropathy, etc.). 
In conclusion, from the results reported here, but 
not in previous literature, we strongly suggest guide 
dog as the treatment of choice for enhancing blind 
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Sažetak
UTJECAJ PSA VODIčA NA REGULACIJU GLIKEMIJE U SLIJEPIH/SLABOVIDNIH OSOBA SA 
ŠEćERNOM BOLEŠćU
B. Korljan-Babić, S. Baršić-Ostojić, Ž. Metelko, N. Car, M. Prašek, V. Škrabić i S. Kokić
Cilj je bio procijeniti regulaciju glikemije kod slijepe osobe sa šećernom bolešću nakon što je ta osoba dobila psa vodiča. 
Retrospektivno su se prikupljali rezultati HbA1c u slijepe osobe prije i nakon dobivanja psa vodiča. Primjenom rezultata 
parnog t-testa dobivena je dvosmjerna vrijednost P od 0,0925. Razlika nije bila statistički značajna, dok se 95% interval po-
uzdanosti te razlike kretao od -0,2494 do 1,889. Zabilježeno je poboljšanje regulacije glikemije uz psa vodiča u usporedbi 
s vrijednostima prije dobivanja psa vodiča, ali razlika nije bila statistički značajna. Smatramo da bi to umjereno poboljšanje 
moglo biti povezano s pokretljivošću slijepe osobe uz psa vodiča. U procjenu slijepe osobe sa šećernom bolešću treba uklju-
čiti standardne testove za kvalitetu života, osobito utjecaj psa na regulaciju glikemije ili na druge kronične komplikacije 
šećerne bolesti.
Ključne riječi: Dijabetes melitus; Dijabetična retinopatija; Hemoglobin A, glikozilirani; Sljepoća – rehabilitacija; Psi
